Free Trial

FONAR (NASDAQ:FONR) Announces Earnings Results

FONAR logo with Medical background

FONAR (NASDAQ:FONR - Get Free Report) posted its quarterly earnings data on Wednesday. The medical equipment provider reported $0.29 earnings per share for the quarter, Zacks reports. FONAR had a net margin of 7.68% and a return on equity of 4.95%. The firm had revenue of $24.95 million for the quarter.

FONAR Stock Performance

FONR traded up $0.07 during midday trading on Friday, hitting $14.78. The stock had a trading volume of 6,903 shares, compared to its average volume of 14,580. FONAR has a 1 year low of $14.05 and a 1 year high of $23.41. The business has a fifty day moving average of $15.45 and a 200 day moving average of $15.94. The company has a market cap of $93.54 million, a P/E ratio of 12.85 and a beta of 1.23.

Analyst Upgrades and Downgrades

Separately, StockNews.com downgraded FONAR from a "strong-buy" rating to a "buy" rating in a research report on Saturday, November 16th.

Read Our Latest Stock Analysis on FONAR

FONAR Company Profile

(Get Free Report)

FONAR Corporation, together with its subsidiaries, engages in the research, development, production, and marketing of magnetic resonance imaging (MRI) scanners for the detection and diagnosis of human diseases in the United States. The company operates in two segments, Medical Equipment, and Physician Management and Diagnostic Services.

Featured Stories

Earnings History for FONAR (NASDAQ:FONR)

Should You Invest $1,000 in FONAR Right Now?

Before you consider FONAR, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and FONAR wasn't on the list.

While FONAR currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

12 Stocks Corporate Insiders are Abandoning Cover

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

NVIDIA Earnings: Will it Spark a Rally or Trigger a Sell-Off?
Marjorie Taylor Greene Bought THOUSANDS in Tesla Stock
The EXACT Date of Next Stock Market Crash

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines